73 articles
Jonathan Cheng with Merck Research Laboratories discusses data presented at the European Society for Medical Oncology (ESMO) 2019 Congress on the phas...
Jonathan Steinfeld, global clinical lead for the GSK mepolizumab pediatric asthma indication discusses the recent FDA approval of GSK's Nucala (mepolizu...
Talley discusses the positive results of the phase 2 study on their new investigational drug candidate SQX770, a topical immunomodulator treatment to ex...
As of June 11, 2019, Merck's KEYTRUDA is now FDA approved for first-line treatment of patients with metastatic or with unresectable, recurrent head and ...
Mike Davis, Head of Neurology for UCB, a global biopharmaceutical company in the U.S., discusses the recent FDA approval of NAYZILAM® (midazolam) for t...
CJ Barnum, Ph.D., Director of Neuroscience for INmune Bio discusses the award of a $1 million dollar grant from the Alzheimer's Association to begin a c...
Carol Satler discusses the recent (Nov 2018) FDA approval of Gamifant® (emapalumab-lzsg), the first and only treatment indicated for primary hemophagoc...
Ronald van Vollenhoven, M.D., Ph.D., talks about new, positive, one-year results from a continued Phase 2 study investigating STELARA® (ustekinumab) in...
A Queensland study on pregnant women that uses Sildenafil, a drug that is commonly known as Viagra, has been temporarily stopped after 11 babies died in...
Rachael Jones, 38, talks about the challenges of living with a rare skeletal disorder called X-Linked Hypophosphatemia (XLH), how it has affected her family, and...